MOSCOW — The moment a wound opens, the body begins a quiet chemical war against itself. Inflammatory cells flood the injury site and release reactive oxygen species, molecular fragments that kill bacteria but also assault healthy proteins and lipids, stalling the recovery that should follow. For most wounds, the body resolves that conflict on its own. For chronic injuries, it often cannot, and the inflammatory cascade lingers, compounding damage rather than repairing it.
Bioengineers at Moscow’s NUST MISIS have developed a gel-based wound dressing derived from brown algae that may interrupt that cycle at its most critical moment. The material, based on sodium alginate extracted from the marine algae class Phaeophyceae, embeds synthetic enzyme-mimicking capsules that neutralize reactive oxygen species during the first twenty-four hours after injury. That window is when oxidative damage is most severe and most consequential for long-term healing outcomes.
“Reactive oxygen species in the body are neutralized by certain enzymes, including superoxide dismutase,” said Nikita Yabbarov, associate professor at the NUST MISIS Institute of Biomedical Engineering. The hydrogel mimics that enzyme through metalloporphyrin compounds encapsulated within the alginate matrix. When placed over a wound, the capsules release their payload in a controlled gradient, front-loading delivery to coincide with the inflammatory phase when cellular vulnerability peaks.
Laboratory testing showed no toxic effects on human skin cells after sustained contact with the material. Cell viability remained high throughout the testing period. Macrophages, the immune cells that patrol wound sites, were observed shifting from a pro-inflammatory to a pro-regenerative state, a transition the research team identified as among its most significant findings. The structural integrity of the gel held throughout.
The project sits within NUST MISIS’s “Biomedical Engineering and Biomaterials” strategic initiative, funded under Russia’s Priority 2030 national development framework. Fyodor Senatov, director of the Institute of Biomedical Engineering, leads the broader effort; graduate student Daria Zinovieva contributed to the bench work. Sputnik reported the findings on Wednesday, noting the institute’s pre-clinical results.
NUST MISIS is not alone in pursuing hydrogel-based approaches to wound care. A research team at KAIST, South Korea’s national science institute, earlier this year unveiled a sprayable hydrogel powder that converts blood into a physical barrier in roughly one second, outperforming commercial hemostatics in animal trials. Both efforts reflect a global convergence on polymer matrices as the next generation of wound intervention, moving beyond antibiotics and compression to address the biochemical conditions that determine whether a wound heals or stalls.
Where the KAIST material targets active hemorrhage, the NUST MISIS formulation addresses the inflammatory aftermath, the days immediately following injury when oxidative stress does its quietest and most lasting damage. The distinction matters clinically. A chronic skin ulcer or battlefield wound that bleeds and then fails to close represents two separate problems requiring two separate interventions, and most existing dressings address only one.
Algae-derived compounds have attracted increasing attention in pharmaceutical research over the past decade. Chitosan from shellfish and alginate from brown algae are the two most studied marine biopolymers for wound applications, and both have demonstrated compatibility with human tissue that synthetic alternatives have historically struggled to match. The NUST MISIS team is building on that literature, adding an active enzyme-mimicking agent to a carrier material that is already well understood.
Sodium alginate’s commercial history, a component of approved food thickeners and pharmaceutical gels for decades, gives the material a regulatory foundation that fully synthetic polymers lack. The compound can be sourced at industrial scale, does not require refrigeration, and carries a documented biocompatibility profile that should ease the path toward clinical licensing, particularly within Russia’s domestic healthcare system.
Russia’s academic institutions have been building new scientific partnerships outside Western research frameworks. Universities within NUST MISIS’s orbit signed cooperation agreements with Malaysian counterparts at a joint commission session in Vladivostok this week, one of several recent moves by Moscow to establish scientific networks that do not depend on access to European or North American institutions. The biomedical programme reflects the same orientation toward domestic production and self-reliance in critical technologies.
The National University of Science and Technology MISIS is one of Russia’s leading technical universities, with programmes spanning materials science, metallurgy, and biomedical engineering. The Priority 2030 framework under which this hydrogel research is funded is a state investment programme designed to accelerate Russian university research across ten strategic domains, including biomedicine.
The team has identified skin injuries and chronic wounds as the primary target population, with future applications potentially extending to mucous membrane repair. Yabbarov described prolonged inflammation as particularly dangerous in chronic skin conditions, where standard wound dressings address surface contamination but leave the underlying cellular environment impaired.
What has not been answered is whether the gel will hold up beyond the laboratory. Clinical trials have not been announced, and no peer-reviewed journal publication was cited in the original announcement. The material has not been tested in the contaminated, irregularly managed environments where wound care most often fails. What the NUST MISIS team has demonstrated is a proof of concept: that brown algae, one of the ocean’s oldest and most chemically versatile organisms, may carry within its structure a mechanism that years of synthetic drug development has worked to replicate with considerably more expensive and complex compounds.
Related Posts
